Manuel Litchman MD - 18 Mar 2022 Form 4 Insider Report for MUSTANG BIO, INC. (MBIO)

Role
Director
Signature
/s/ Matthew Wein, Attorney-in-Fact
Issuer symbol
MBIO
Transactions as of
18 Mar 2022
Net transactions value
+$6,277
Form type
4
Filing time
03 Apr 2023, 16:51:42 UTC
Previous filing
08 Nov 2021
Next filing
04 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MBIO COMMON STOCK, PAR VALUE $0.0001 Purchase $3,695 +5,000 +0.49% $0.7390 1,032,987 18 Mar 2022 Direct F1, F2
transaction MBIO COMMON STOCK, PAR VALUE $0.0001 Award $0 +61,000 +5.9% $0.000000 1,093,987 21 Jun 2022 Direct F2, F3
transaction MBIO COMMON STOCK, PAR VALUE $0.0001 Purchase $2,582 +5,000 +0.46% $0.5164 1,098,987 13 Sep 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired as purchases made under the Issuer's Employee Stock Purchase Plan ("ESPP") during the ESPP offering period.
F2 Includes restricted share units, which vest over various time periods.
F3 Represents an award of 61,000 restricted stock units that will vest in four annual installments after the grant date, vesting in full on April 24, 2026.